To, Minh D.

K-Ras promotes tumorigenicity through suppression of non-canonical Wnt signaling

Wang, M.-T., Holderfield, M., Galeas, J., Delrosario, R., To, M. D., Balmain, A., & McCormick, F. (2015) · Cell

Protein Kinase Regulation and GTPase SignalingWnt/β-catenin signaling in development and cancer

Cited by 196

α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas

Dodagatta-Marri, E., Meyer, D. S., Reeves, M. Q., Paniagua, R., To, M. D., Binnewies, M., Broz, M. L., Mori, H., Wu, D., Adoumie, M., et al. (2019) · Journal for ImmunoTherapy of Cancer

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 177

The genetics and biology of KRAS in lung cancer

Westcott, P. M. K., & To, M. D. (2013) · Chinese Journal of Cancer

Protein Kinase Regulation and GTPase SignalingLung Cancer Treatments and Mutations

Cited by 116